July 17, 2023 — Chronic inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis, is on the rise worldwide. The benefits of current medications are limited by problematic ...
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to ...
A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as ...
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
A NEW method for detecting bowel cancer is more than 90 per cent accurate at predicting which higher risk people will develop ...
Mirikizumab showed superior maintenance efficacy over most treatments for ulcerative colitis (UC), according to a network ...
Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...
healthday on MSN1d
Inflammatory Bowel Disease Tied to Higher Risk for Heart DiseaseMale patients with inflammatory bowel disease (IBD) face a higher risk for ischemic heart diseases (IHDs), according ...
THE fact that extension of the inflammatory process to the terminal portion of the ileum occurs in patients with chronic ulcerative colitis is ... until 1932 by Crohn, Ginzburg and Oppenheimer ...
Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...
The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback